Phase I/II Trial of S-1 and Nedaplatin with concurrent radiotherapy in locally advanced mesopharynx, hypopharynx cancer - Phase I/II Trial of S-1 and Nedaplatin with concurrent radiotherapy in locally advanced mesopharynx, hypopharynx cancer

Kitasato University School of Medicine0 个研究点目标入组 43 人开始时间: 2010年7月9日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)active double cancer 2)severe complications (congested heart failure, coronary insufficiency, myocardial infarction, angina pectoris or abnormal cardiac rhythm which need to treat, history of cerebrovascular accident, hemorrhagic gastrointestinal ulceration, uncontrolled diabetes, renal failure, active hepatitis, liver cirrhosis) 3)develop fever and suspected infection 4)motor palsy, peripheral neuropathy or edema (exclude the disorder which derives from primary disease) 5)pleural effusion which need to treat or pericardial effusions 6)pregnant or nursing women or women who like be pregnant and men with partner willing to get pregnant 7)interstitial pneumonitis which is revealed from chest X ray and chest CT 8)history of mental disorder or treating it at the moment 9)history of severe allergy 10)severe allergy to S-1 or Nedaplatin 11)patients receiving 5-FU based chemotherapy 12)patients receiving Flucytosine 13)doctors decision not to be registered to this study

发起方

Kitasato University School of Medicine